Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study

Lee, Doo-Ho; Kim, Doojin; Park, Yeon Ho; Yoon, Jinmyeong; Kim, Joo Seop

doi:10.1016/j.asjsur.2020.05.028

Cited by 16 publications

(16 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…LLR or OLR has no effect on the survival time of patients after surgery. LLR has advantages in terms of reducing operating time, length of hospital stays, and postoperative complications [11][12][13][14]. LLR is recommended if there is no special requirement and the surgical indication is suitable.…”

Section: Discussionmentioning

confidence: 99%

The influencing factors and survival rate of pulmonary metastasis after liver resection :a retrospective cohort study

Dai

2020

Preprint

View full text Add to dashboard Cite

Background: Pulmonary metastasis(PM) form hepatocellular carcinoma(HCC) is a major indicator of a poor prognosis after liver resection. The study aimed to probe into the influencing factors for PM following open liver resection(OLR) and laparoscopic liver resection(LLR) with HCC. Method: All patients who suffered from LLR and OLR for primary HCC, who developed pulmonary metastasis, as first extrahepatic metastasis, were retrospectively analyzed in our department from January 2014 to August 2020. Results: Thirty-three cases were included (median age 50 years,81.8% male). The patients with a single tumor had 23 cases (69.7%), and a total of 10 patients(30.3%) has two and more tumors. 21 cases (63.6%) were smaller than 10 cm of tumor diameter. The median of operation time was 200 minutes (110-360), Portal vein occlusion occurred in 12 patients(36.4%). Patients with intrahepatic recurrence received vertebroplasty combined chemotherapy(VPCC), targeted therapy , trans-arterial chemo-embolization(TACE) and radio frequency catheter ablation(RFCA) in 1(3%),1(3%),10(30.3%) and 7(12.1%) cases respectively. The 2-and 3-year cumulative probability of overall survival (OS) were 63% and 41%. The median OS was 30.8 months. The median recurrence time was 6 months(1.7-4.8). The median of confirmed PM time from HCC was 12.5 months(1.5-61.1) and 17(51.5%) patients died. Conclusion: Early detection of intrahepatic recurrence and treatment can prolong PM time and overall survival time.

show abstract

Section: Discussionmentioning

confidence: 99%

The influencing factors and survival rate of pulmonary metastasis after liver resection :a retrospective cohort study

Dai

2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Pneumoperitoneum was established through the 10 mm umbilical port and was kept below 12 mmHg to reduc e the risk of air embolism. Laparoscopic ultrasound is used to localize the tumor, demonstrate satellite nodules, and mark an adequate tumor-free margin [17].…”

Section: Types Of Interventionsmentioning

confidence: 99%

“…After careful hemostasis, fibrin glue sealant and a sealant patch were applied to the cut surface of the liver. Finally, after irrigating the surgical field, one or two silastic drains are inserted [17]. It was inserted into a protective bag and removed through the incision created by extending the umbilical port site.…”

Section: Types Of Interventionsmentioning

confidence: 99%

See 1 more Smart Citation

Eficacia de la hepatectomía robótica frente a la hepatectomía laparoscópica en pacientes con tumores hepáticos

Palomeque¹,

Castro²,

Izquierdo

2021

REV-SEP

View full text Add to dashboard Cite

Introducción: La resección hepática sigue siendo el método más efectivo de tratamiento de tumores hepáticos. Actualmente, el abordaje laparoscópico se considera como el estándar de oro frente al abordaje abierto; sin embargo, el surgimiento de la cirugía robótica brinda una nueva opción de abordaje mínimamente invasiva con aparentes mejores resultados. El objetivo de esta revisión sistemática es valorar los beneficios de la hepatectomía robótica frente a la hepatectomía laparoscópica en la resección de tumores hepáticos. Metodología: En esta revisión sistemática se incluirán estudios comparativos, de cohorte, de casos y controles, con recolección de datos prospectivos o retrospectivos. Los participantes de los estudios serán pacientes diagnosticados con tumores hepáticos benignos o malignos, incluidos niños y adolescentes, no cirróticos o cirróticos compensados sometidos a intervenciones de hepatectomía robótica y hepatectomía laparoscópica. Las medidas de resultado primarias son: 1. Pérdida de sangre estimada durante el acto quirúrgico, 2. Tiempo operatorio, 3. Tasa de conversión a laparotomía, 4. Tasa de mortalidad intraoperatoria, 5. Tasa de morbilidad (complicaciones postquirúrgicas), 6. Estancia hospitalaria postquirúrgica. Las búsquedas electrónicas se realizarán en PUBMED, MEDLINE, SCIENCEDIRECT (2010 hasta el presente). Se usará la evaluación del riesgo de sesgo de estudios de Cochrane. Como medidas de efecto del tratamiento se utilizarán las diferencias de medias (DM) y los intervalos de confianza (IC) del 95. La evaluación de heterogeneidad se realizará mediante la inspección visual del diagrama de embudo. La evaluación de la calidad de la evidencia y tablas de 'Resumen de hallazgos' se usará el test GRADE.

show abstract

“…At present, the industry still maintains a cautious attitude towards the transition to laparotomy because intraoperative bleeding is difficult to effectively control for the safe integration of laparoscopic large-scale hepatectomy or postoperative bleeding. Recent evidence from some centers has shown that laparoscopic hepatectomy is acceptable for HCC patients who meet the surgical criteria, and there is no significant difference in postoperative survival time [29,30] . Rao et al [31] compared 700 patients who underwent pure laparoscopic liver resection and laparotomy.…”

Section: Laparoscopic Hepatectomymentioning

confidence: 99%

Advances in minimally invasive surgery for hepatocellular carcinoma

Zhang¹,

Li²

2020

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer-related death worldwide. Surgical resection is still regarded as the first choice of treatment for HCC. With advances in technology and techniques, minimally invasive surgery has now become the standard of care in almost every field in general surgery, including hepatectomy surgery. This review focuses on the latest advances in minimally invasive surgical treatment of HCC, including laparoscopic hepatectomy (LH), robotic hepatectomy (RH) and other minimally invasive treatment technologies. Although some limitation in LH or RH exists, these minimally invasive techniques may be performed for hepatectomy with benefits, and have a promising future. With the development of technology and the improvement of surgical operations, patients will benefit from this.

show abstract

Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study

Cited by 16 publications

References 25 publications

The influencing factors and survival rate of pulmonary metastasis after liver resection :a retrospective cohort study

The influencing factors and survival rate of pulmonary metastasis after liver resection :a retrospective cohort study

Eficacia de la hepatectomía robótica frente a la hepatectomía laparoscópica en pacientes con tumores hepáticos

Advances in minimally invasive surgery for hepatocellular carcinoma

Contact Info

Product

Resources

About